Skip to main content
AstraZeneca PLC (STO:AZN)
Sweden flag Sweden · Delayed Price · Currency is SEK
1,344.50
+26.00 (1.97%)
Apr 15, 2025, 5:29 PM CET

AstraZeneca Revenue

In the year 2024, AstraZeneca had annual revenue of $54.07B USD with 18.03% growth. AstraZeneca had revenue of $14.89B in the quarter ending December 31, 2024, with 23.84% growth.

Revenue
$54.07B
Revenue Growth
+18.03%
P/S Ratio
3.47
Revenue / Employee
$573.41K
Employees
94,300
Market Cap
2,076.72B SEK

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.03B
Getinge AB 34.76B
Sectra AB 3.30B
Camurus AB 1.87B
Medicover AB 23.97B
Vitrolife AB 3.61B
Vimian Group AB 4.29B
Bonesupport Holding AB 898.73M
Revenue Rankings

AstraZeneca News

More News